These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8004881)

  • 1. Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics.
    Chen YL; Le Vraux V; Leneveu A; Dreyfus F; Stheneur A; Florentin I; De Sousa M; Giroud JP; Flouvat B; Chauvelot-Moachon L
    Clin Pharmacol Ther; 1994 Jun; 55(6):649-60. PubMed ID: 8004881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acute phase response in autologous bone marrow transplantation.
    Boosalis MG; Gray D; Walker S; Sutliff S; Talwalker R; Mazumder A
    J Med; 1992; 23(3-4):175-93. PubMed ID: 1479299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
    Lehle K; Kirchner GI; Rupprecht L; Gruber M; Birnbaum DE; Schmid FX; Preuner JG
    Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response.
    Lacki JK; Leszczynski P; Kelemen J; Müller W; Mackiewicz SH
    J Med; 1997; 28(1-2):99-107. PubMed ID: 9249616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients.
    Hermann M; Asberg A; Christensen H; Reubsaet JL; Holdaas H; Hartmann A
    Eur J Clin Pharmacol; 2005 Mar; 61(1):59-62. PubMed ID: 15711834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of cyclosporine A on the acute phase response in mice and humans.
    Dyck RF; Owen PS
    Transplant Proc; 1989 Apr; 21(2):3317-8. PubMed ID: 2496505
    [No Abstract]   [Full Text] [Related]  

  • 7. The concentration of cyclosporine metabolites is significantly lower in kidney transplant recipients with diabetes mellitus.
    Akhlaghi F; Dostalek M; Falck P; Mendonza AE; Amundsen R; Gohh RY; Asberg A
    Ther Drug Monit; 2012 Feb; 34(1):38-45. PubMed ID: 22210099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 10 inhibits interleukin 6 production and acute phase response in rheumatoid arthritis.
    Lacki JK; Klama K; Porawska W; Mackiewicz SH; Müller W; Wiktorowicz K
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):11-4. PubMed ID: 8744678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose daily infusion of cyclosporine for prevention of Graft-versus-host disease after allogeneic bone marrow transplantation from HLA allele-matched, unrelated donors.
    Nawa Y; Hara M; Tanimoto K; Nakase K; Kozuka T; Maeda Y
    Int J Hematol; 2006 Feb; 83(2):159-63. PubMed ID: 16513536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic drug interaction between cyclosporine and imatinib in bone marrow transplant children and model-based reappraisal of imatinib drug interaction profile.
    Bleyzac N; Kebaili K; Mialou V; Bertrand Y; Goutelle S
    Ther Drug Monit; 2014 Dec; 36(6):724-9. PubMed ID: 24739665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients.
    Kaysen GA; Dubin JA; Müller HG; Rosales L; Levin NW; Mitch WE;
    Kidney Int; 2004 Apr; 65(4):1408-15. PubMed ID: 15086482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cyclosporine A at a high-peak concentration of twice-daily infusion and oral administration in allogeneic haematopoietic stem cell transplantation.
    Inoue Y; Saito T; Ogawa K; Nishio Y; Kosugi S; Suzuki Y; Shibuya Y; Kato M; Takahashi M; Miura I
    J Clin Pharm Ther; 2011 Aug; 36(4):518-24. PubMed ID: 21105879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine monitoring improves graft-versus-host disease prophylaxis after bone marrow transplantation.
    Ghalie R; Fitzsimmons WE; Weinstein A; Manson S; Kaizer H
    Ann Pharmacother; 1994 Mar; 28(3):379-83. PubMed ID: 8193430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
    Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
    Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine markedly raises the plasma concentrations of repaglinide.
    Kajosaari LI; Niemi M; Neuvonen M; Laitila J; Neuvonen PJ; Backman JT
    Clin Pharmacol Ther; 2005 Oct; 78(4):388-99. PubMed ID: 16198658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft function based on two hours peak level monitoring of cyclosporine A during the first six months of renal transplantation.
    Hami M; Naghibi M; Mojahedi MJ; Sharifipour F; Shakeri MT
    Saudi J Kidney Dis Transpl; 2012 Nov; 23(6):1169-74. PubMed ID: 23168844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent.
    Kaplan B; Meier-Kriesche HU; Napoli KL; Kahan BD
    Clin Pharmacol Ther; 1998 Jan; 63(1):48-53. PubMed ID: 9465841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism.
    Shedlofsky SI; Israel BC; McClain CJ; Hill DB; Blouin RA
    J Clin Invest; 1994 Dec; 94(6):2209-14. PubMed ID: 7989576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodontal therapy: a novel non-drug-induced experimental model to study human inflammation.
    D'Aiuto F; Nibali L; Mohamed-Ali V; Vallance P; Tonetti MS
    J Periodontal Res; 2004 Oct; 39(5):294-9. PubMed ID: 15324349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.